Literature DB >> 16609988

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Peter Laszlo Lakatos1, Simon Fischer, Laszlo Lakatos, Istvan Gal, Janos Papp.   

Abstract

The pathogenesis of inflammatory bowel disease (IBD) is only partially understood. Various environmental and host (e.g. genetic-, epithelial-, immune and non-immune) factors are involved. It is a multifactorial polygenic disease with probable genetic heterogeneity. Some genes are associated with IBD itself, while others increase the risk of ulcerative colitis (UC) or Crohn's disease (CD) or are associated with disease location and/or behaviour. This review addresses recent advances in the genetics of IBD. The article discusses the current information on the crosstalk between microbial and genetic factors (e.g. NOD2/CARD15, SLC22A46A5 and DLG5). The genetic data acquired in recent years help in understanding the pathogenesis of IBD and can identify a number of potential targets for therapeutic intervention. In the future, genetics may help more accurately diagnose and predict disease course in IBD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16609988      PMCID: PMC4087507          DOI: 10.3748/wjg.v12.i12.1829

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  169 in total

1.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

2.  Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.

Authors:  H-P Török; J Glas; L Tonenchi; P Lohse; B Müller-Myhsok; O Limbersky; C Neugebauer; F Schnitzler; J Seiderer; C Tillack; S Brand; G Brünnler; P Jagiello; J T Epplen; T Griga; W Klein; U Schiemann; M Folwaczny; T Ochsenkühn; C Folwaczny
Journal:  Gut       Date:  2005-06-14       Impact factor: 23.059

3.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

4.  Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha.

Authors:  F M Ruemmele; J F Beaulieu; S Dionne; E Levy; E G Seidman; N Cerf-Bensussan; M J Lentze
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

5.  Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders.

Authors:  J Hampe; K Heymann; W Kruis; A Raedler; U R Fölsch; S Schreiber
Journal:  Am J Med Genet       Date:  2000-05-29

6.  Crohn's disease after in-utero measles virus exposure.

Authors:  A Ekbom; P Daszak; W Kraaz; A J Wakefield
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

7.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

8.  Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease.

Authors:  M F Neurath; I Fuss; G Schürmann; S Pettersson; K Arnold; H Müller-Lobeck; W Strober; C Herfarth; K H Büschenfelde
Journal:  Ann N Y Acad Sci       Date:  1998-11-17       Impact factor: 5.691

9.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

10.  NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.

Authors:  Mihai G Netea; Bart Jan Kullberg; Dirk J de Jong; Barbara Franke; Tom Sprong; Ton H J Naber; Joost P H Drenth; Jos W M Van der Meer
Journal:  Eur J Immunol       Date:  2004-07       Impact factor: 5.532

View more
  40 in total

Review 1.  Peptidoglycan recognition proteins: modulators of the microbiome and inflammation.

Authors:  Julien Royet; Dipika Gupta; Roman Dziarski
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

Review 2.  Management of Crohn's disease in smokers: is an alternative approach necessary?

Authors:  Pilar Nos; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

Review 3.  Family 6 glycosyltransferases in vertebrates and bacteria: inactivation and horizontal gene transfer may enhance mutualism between vertebrates and bacteria.

Authors:  Keith Brew; Percy Tumbale; K Ravi Acharya
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 4.  Smoking in inflammatory bowel diseases: good, bad or ugly?

Authors:  Peter Laszlo Lakatos; Tamas Szamosi; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 5.  A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics.

Authors:  L Vitetta; D Briskey; E Hayes; C Shing; J Peake
Journal:  Inflammopharmacology       Date:  2012-03-18       Impact factor: 4.473

Review 6.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

7.  Risk haplotype analysis for bovine paratuberculosis.

Authors:  Pablo J Pinedo; Chenguang Wang; Yao Li; D Owen Rae; Rongling Wu
Journal:  Mamm Genome       Date:  2009-01-15       Impact factor: 2.957

8.  The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis.

Authors:  Tomiyasu Arisawa; Tomomitsu Tahara; Tomoyuki Shibata; Mitsuo Nagasaka; Masakatsu Nakamura; Yoshio Kamiya; Hiroshi Fujita; Masahiko Nakamura; Daisuke Yoshioka; Yuko Arima; Masaaki Okubo; Ichiro Hirata; Hiroshi Nakano
Journal:  J Clin Immunol       Date:  2007-09-09       Impact factor: 8.317

Review 9.  Ras-oncogenic Drosophila hindgut but not midgut cells use an inflammation-like program to disseminate to distant sites.

Authors:  Theodoulakis Christofi; Yiorgos Apidianakis
Journal:  Gut Microbes       Date:  2012-10-12

10.  Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population.

Authors:  Ravi Verma; Vineet Ahuja; Jaishree Paul
Journal:  BMC Med Genet       Date:  2009-09-01       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.